Neurofenix raises £5.9m in Series A funding led by AlbionVC to support US expansion.
The Series A round was led by AlbionVC with participation from HTH and InHealth Ventures.
Neurofenix develops digital rehabilitation platforms combining sensor-based technology and telemedicine for neurological patients. The company focuses on improving recovery outcomes through gamified home therapy programmes.
Neurofenix has secured £5.9m in Series A funding to expand its product team and accelerate its presence in the United States. The investment round was led by AlbionVC, with participation from HTH, InHealth Ventures, and existing backers.
Founded in 2016, the company combines sensor-based hardware, such as the NeuroBall device, with a bespoke telemedicine portal to support remote neurological rehabilitation. The fresh capital will be directed towards product development and clinical trials Stateside.
From the founder
"Over the last six years, we have been creating and developing our patient-centric sensor-based technology and platform to transform neuro-rehab. In clinical studies, NeuroBall was proven to motivate patients to do hundreds of movement repetitions independently at home, which led to significant improvements in the range of motion, reduction of arm pain and return to daily activities using their arm and hand after a stroke. This has proven transformative to neuro-rehab as previously patients would not have access to in-person physical or occupational therapy due to factors such as insurance, financial, transportation and health barriers. We’re excited to partner with AlbionVC, HTH, and InHealth Ventures, and are hugely grateful for their support to scale our unique neurological therapeutics platform that we believe will change the world of neuro-rehab."
Guillem Singla Buxarrais
CEO at Neurofenix
Investor perspective
"Neurofenix is poised to revolutionize physical recovery after a neurological injury, such as a stroke, traumatic brain injury or spinal cord injury. Its digital therapeutics platform, which can be used in rehabilitation clinics and by an individual bringing clinical-grade treatment into the home, which generates recovery of movement, strength, and activities of daily living faster and with better results. With my background as a neurosurgeon, I could see that Neurofenix is positioned to fill a major gap in the neuro-rehab industry."
Andrew Elder
Deputy Managing Partner, AlbionVC
Use of funds
- 01Continue product development
- 02Expand into international markets
Investors
Categories
About the company
Neurofenix
Neurofenix builds sensor-based technology and telemedicine platforms for neurological rehabilitation.